ENG/中
老虎證券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
泰格醫藥
26.550
-0.200
-0.75%
手動刷新
成交量:
96.74萬
成交額:
2,567.27萬
市值:
229.64億
市盈率:
53.10
高:
26.950
開:
26.550
低:
26.150
收:
26.750
資料載入中...
總覽
公司
新聞
公告
【石藥集團(01093.HK):JMT203(抗GFRAL單克隆抗體)獲美國臨牀試驗批准】石藥集團(01093.HK)發佈公告,公司附屬公司上海津曼特生物科技有限公司自主研發的抗體藥物JMT203已獲美國食品藥品監督管理局(FDA)批准,可以在美國開展臨牀研究。此前,該產品已經於2023年6月獲得中國國家藥品監督管理局批准,並正在中國開展臨牀試驗。
金融界
·
04-22
石藥集團(01093):JMT203(抗GFRAL單克隆抗體)獲美國臨牀試驗批准
智通财经
·
04-22
科倫博泰生物-B現漲超4% 創新ADC藥物SKB518新藥臨牀試驗申請獲FDA批准
新浪港股
·
04-22
醫藥外包概念全線飄紅 藥明生物(02269)漲超3% 機構指板塊存在超跌機會 FDA新政下AI製藥價值凸顯
金吾财讯
·
04-22
中歐基金葛蘭:看好創新藥、消費醫療、醫療設備等板塊投資機遇
美港电讯
·
04-22
港股異動 | 先聲藥業(02096)現漲超8% SIM0686獲準開展臨牀試驗 後續多款新藥獲批在望
智通财经
·
04-22
奧辰生物(雲南)有限公司藥品申請臨牀試驗默示許可獲受理
金融界
·
04-21
吉利德科學(GILD.O)宣佈Trodelvy(戈沙妥珠單抗)聯合Keytruda(帕博利珠單抗)在第三級臨牀試驗中達到
美港电讯
·
04-21
科倫藥業:子公司SKB518新藥臨牀試驗申請獲FDA批准
美港电讯
·
04-21
科倫博泰生物-B(06990):創新ADC藥物SKB518新藥臨牀試驗申請獲美國食品藥品監督管理局批准
智通财经
·
04-21
恆瑞醫藥:子公司收到藥物臨牀試驗批准通知書
美港电讯
·
04-21
【百奧泰:注射用BAT7111獲藥物臨牀試驗批准】百奧泰公告,公司於近日收到國家藥監局覈准簽發的《藥物臨牀試驗批准通知書》,公司在研藥品注射用BAT7111用於晚期實體瘤的臨牀試驗申請獲得批准。根據《Clinical Development Success Rates2011-2020》公佈的數據,通常情況下對於抗腫瘤藥物,一般I/II期臨牀研究階段持續約2年時間,I期完成進入II期的比率約48.8%,II期完成進入III期的比率約24.6%。考慮到臨牀研究週期長、投入大,過程中不可預測因素較多,臨牀試驗、審評和審批的結果以及時間都具有一定的不確定性。
金融界
·
04-21
中國人民銀行等四部門:加大對出口企業的保險支持力度
美港电讯
·
04-21
晚期實體瘤藥物喜訊不斷,人福醫藥、匯宇製藥、翰森製藥等多藥企獲批臨牀試驗
动脉网
·
04-21
【改善患者肢體運動功能 “植入式迷走神經刺激系統”臨牀試驗啓動】今天,國家衞生健康委組織實施的“百萬減殘”工程重點推廣項目,我國自主研發的“植入式迷走神經刺激系統”臨牀試驗正式全國啓動。該項目有望成為我國卒中後殘疾防控的重要手段。
金融界
·
04-19
Sands Capital Management,LP減持泰格醫藥(03347)38.41萬股 每股作價為25.9329港元
智通财经
·
04-18
【沃森生物:20價肺炎球菌多糖結合疫苗獲臨牀試驗批准】沃森生物公告,公司及子公司共同申請的20價肺炎球菌多糖結合疫苗獲得國家藥品監督管理局簽發的《藥物臨牀試驗批准通知書》,通知書編號為2025LP01099。該疫苗是在已上市產品13價肺炎球菌多糖結合疫苗基礎上開發的迭代升級產品,新增了8型、10A型、11A型、12F型、15B型、22F型和33F型共計7種血清型,用於預防由本品所含20種肺炎球菌血清型引起的感染性疾病。全球已上市20價肺炎球菌多糖結合疫苗的廠家僅有美國輝瑞公司一家,國內尚未有20價肺炎球菌多糖結合疫苗上市銷售。
金融界
·
04-18
盛禾(中國)生物製藥有限公司藥品申請臨牀試驗默示許可獲受理
金融界
·
04-18
石藥集團歐意藥業有限公司藥品申請臨牀試驗默示許可獲受理
金融界
·
04-18
普方生物製藥(蘇州)有限公司藥品申請臨牀試驗默示許可獲受理
金融界
·
04-18
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/03347/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"03347","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03347\",,,,,undefined,":{"symbol":"03347","market":"HK","secType":"STK","nameCN":"泰格醫藥","latestPrice":26.55,"timestamp":1745827737031,"preClose":26.75,"halted":0,"volume":967375,"delay":0,"floatShares":123000000,"shares":864948570,"eps":0.49997978987294633,"marketStatus":"未開盤","change":-0.2,"latestTime":"04-28 16:08:57","open":26.55,"high":26.95,"low":26.15,"amount":25672685,"amplitude":0.029907,"askPrice":26.55,"askSize":4500,"bidPrice":26.4,"bidSize":4000,"shortable":3,"etf":0,"ttmEps":0.49997978987294633,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1745890200000},"marketStatusCode":0,"adr":0,"listingDate":1596729600000,"exchange":"SEHK","adjPreClose":26.75,"dividendRate":0.012032,"openAndCloseTimeList":[[1745803800000,1745812800000],[1745816400000,1745827200000]],"volumeRatio":0.3579225658125836,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"300347","market":"SZ","secType":"STK","nameCN":"泰格醫藥","latestPrice":44.15,"timestamp":1745823600000,"preClose":45.05,"halted":0,"volume":6135600,"delay":0,"premium":"-43.54"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03347\",,,,,undefined,":{"symbol":"03347","floatShares":123000000,"roa":"2.16%","roe":"1.85%","lyrEps":0.49998,"volumeRatio":0.3579225658125836,"shares":864948570,"dividePrice":0.319519,"high":26.95,"amplitude":0.029907,"preClose":26.75,"low":26.15,"week52Low":22.3,"pbRate":"1.04","psRate":"3.27","week52High":58.8,"institutionHeld":0,"latestPrice":26.55,"committee":-0.058824,"eps":0.49997978987294633,"divideRate":0.012032,"volume":967375,"delay":0,"ttmEps":0.49997978987294633,"open":26.55,"prevYearClose":30.8,"prevWeekClose":26.75,"prevMonthClose":31,"prevQuarterClose":31,"fiveDayClose":25.6,"twentyDayClose":34.45,"sixtyDayClose":28.9},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"03347\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529303940","title":"【石藥集團(01093.HK):JMT203(抗GFRAL單克隆抗體)獲美國臨牀試驗批准】石藥集團(01093.HK)發佈公告,公司附屬公司上海津曼特生物科技有限公司自主研發的抗體藥物JMT203已獲美國食品藥品監督管理局(FDA)批准,可以在美國開展臨牀研究。此前,該產品已經於2023年6月獲得中國國家藥品監督管理局批准,並正在中國開展臨牀試驗。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529303940","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529303940?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 19:56","pubTimestamp":1745322961,"startTime":"0","endTime":"0","summary":"石药集团(01093.HK)发布公告,公司附属公司上海津曼特生物科技有限公司自主研发的抗体药物JMT203已获美国食品药品监督管理局(FDA)批准,可以在美国开展临床研究。此前,该产品已经于2023年6月获得中国国家药品监督管理局批准,并正在中国开展临床试验。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/22195649765915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["03347","LU0880133367.SGD","LU1993786604.SGD","LU1226287529.USD","LU1152091168.USD","IE0008369823.USD","IE00B031HY20.USD","159837","LU1226288170.HKD","LU0067412154.USD","LU1226287792.SGD","IE00BZ08YR35.GBP","01093","IE0008368742.USD","SG9999004220.SGD","IE00BZ08YT58.USD","IE00B543WZ88.USD","LU1226287875.USD","LU1226288253.USD","BK1515","BK1583","IE00BZ08YS42.EUR","LU0501845795.SGD","LU0072913022.USD","LU1008478684.HKD","LU1951186391.HKD","BK1576","IE00B5MMRT66.SGD","LU1960683339.HKD","BK1521","LU1807302812.USD","BK1141","LU0140636845.USD","LU0326950275.SGD","BK1191","LU1152091754.HKD"],"gpt_icon":0},{"id":"2529303815","title":"石藥集團(01093):JMT203(抗GFRAL單克隆抗體)獲美國臨牀試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2529303815","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529303815?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 19:53","pubTimestamp":1745322794,"startTime":"0","endTime":"0","summary":"智通财经APP讯,石药集团 发布公告,公司附属公司上海津曼特生物科技有限公司自主研发的抗体药物JMT203已获美国食品药品监督管理局批准,可以在美国开展临床研究。此前,该产品已经于2023年6月获得中国国家药品监督管理局批准,并正在中国开展临床试验。目前,全球范围内尚未有GDF15或GFRAL靶点药物上市,该产品有望成为治疗肿瘤恶病质的有效药物,具有较高的临床开发价值。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282464.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BZ08YR35.GBP","BK1521","BK1141","LU1152091754.HKD","IE00BZ08YT58.USD","IE00B543WZ88.USD","LU0880133367.SGD","LU1226287529.USD","03347","LU1951186391.HKD","LU1226287792.SGD","LU1226288253.USD","BK1583","IE0008369823.USD","IE00B031HY20.USD","LU1008478684.HKD","BK1191","01093","LU1993786604.SGD","IE00B5MMRT66.SGD","LU0067412154.USD","IE00BZ08YS42.EUR","IE0008368742.USD","LU1152091168.USD","LU0072913022.USD","LU0501845795.SGD","LU1807302812.USD","LU0140636845.USD","LU0326950275.SGD","SG9999004220.SGD","LU1226288170.HKD","LU1960683339.HKD","BK1576","LU1226287875.USD","BK1515"],"gpt_icon":0},{"id":"2529446391","title":"科倫博泰生物-B現漲超4% 創新ADC藥物SKB518新藥臨牀試驗申請獲FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2529446391","media":"新浪港股","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529446391?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 11:06","pubTimestamp":1745291160,"startTime":"0","endTime":"0","summary":" 科伦博泰生物-B盘中涨超5%,截至发稿,股价上涨4.21%,现报297.40港元,成交额1.70亿港元。 4月21日,科伦博泰生物-B发布公告,公司已获得美国食品药品监督管理局批准启动其创新抗体偶联药物药物SKB518临床研究的新药临床试验申请。于2024年6月,公司收到国家药品监督管理局药品审评中心 批准SKB518用于晚期实体瘤的IND申请的临床试验通知书。SKB518的1期临床试验正在中国进行中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-04-22/doc-inetzenw7845847.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1141","06990","BK1583","LU0196878994.USD","03347","BK4080","BK1576","BK1161","ADC","BK4231"],"gpt_icon":0},{"id":"2529431360","title":"醫藥外包概念全線飄紅 藥明生物(02269)漲超3% 機構指板塊存在超跌機會 FDA新政下AI製藥價值凸顯","url":"https://stock-news.laohu8.com/highlight/detail?id=2529431360","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529431360?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 10:14","pubTimestamp":1745288092,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药外包概念全线飘红,药明生物 涨3.17%,凯莱英涨2.55%,昭衍新药涨2.55%,康龙化成涨1.78%,药明康德涨1.73%,金斯瑞生物科技涨1.54%,泰格医药涨1.56%。交银国际研报指,中美多次调整关税政策。FDA称此举旨在加速评估流程,减少动物实验,降低研发成本并最终降低药品价格。该行指,FDA宣布取消动物实验长期有望利好AI制药企业。该行认为市场对于关税对医药板块的影响存在过度担忧,仍存在超跌情况。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210810/ZTUyNTQ0NjcxODUwNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZTUyNTQ0NjcxODUwNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1957468","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","LU2242644610.SGD","LU2039709279.SGD","IE00B0JY6N72.USD","LU0052750758.USD","LU0823426480.USD","LU1242518857.USD","LU0359202008.SGD","01548","09939","LU0181495838.USD","LU1794554557.SGD","LU0516423091.SGD","LU0572944931.SGD","LU0043850808.USD","BK1576","02269","159938","LU2125910500.SGD","SG9999002562.SGD","03759","LU0307460666.USD","02359","LU0588546209.SGD","HK0000320264.USD","LU1242518931.SGD","LU0348825331.USD","LU0348735423.USD","LU0456846285.SGD","HK0000306701.USD","LU0327786744.USD","LU0417516738.SGD","01477","LU0516422440.USD","HK0000306685.HKD","BK1589","06127","LU0823426308.USD","03347","06821","LU0708995583.HKD","LU0320764599.SGD","LU0516422952.EUR","LU0417516902.SGD","LU1720050803.USD","LU1688375341.USD","LU0856984785.SGD","LU2045819591.USD","LU0359201612.USD","BK1574"],"gpt_icon":0},{"id":"2529336012","title":"中歐基金葛蘭:看好創新藥、消費醫療、醫療設備等板塊投資機遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2529336012","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529336012?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 10:13","pubTimestamp":1745287980,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["159891","BK1191","06978","01477","159873","159992","BK1576","BK1161","BK1583","03347","BK1574","BK1141"],"gpt_icon":0},{"id":"2529836273","title":"港股異動 | 先聲藥業(02096)現漲超8% SIM0686獲準開展臨牀試驗 後續多款新藥獲批在望","url":"https://stock-news.laohu8.com/highlight/detail?id=2529836273","media":"智通财经","labels":["executive","productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529836273?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 09:48","pubTimestamp":1745286523,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,先声药业(02096)现涨超8%,截至发稿,涨8.09%,报8.28港元,成交额2817.13万港元。消息面上,先声药业公布,旗下的抗肿瘤候选药物FGFR2b抗体偶联药物SIM0686,已获得中国国家药品监督管理局签发的药物临床试验批准通知书,拟开展晚期实体瘤的临床试验。据介绍,相关药物拟开发用于治疗胃癌和肺癌等晚期恶性肿瘤。华泰证券表示,看好先声药业业绩步入快速增长通道:曲拉西利、西妥昔单抗β纳入医保,先必新医保降价温和,舌下片于24年底获批,有望驱动25年业绩增长;达利雷生、苏维西塔单抗等新药有望于25年获批,贡献增量。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282036.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1141","BK1583","02096","03347","BK1576"],"gpt_icon":0},{"id":"2529809381","title":"奧辰生物(雲南)有限公司藥品申請臨牀試驗默示許可獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2529809381","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529809381?lang=zh_tw&edition=fundamental","pubTime":"2025-04-21 23:15","pubTimestamp":1745248550,"startTime":"0","endTime":"0","summary":"4月21日,据CDE官网消息,奥辰生物(云南)有限公司联合申请药品“TriCellPr-AC07人脐带间充质干细胞注射液”,获得临床试验默示许可,受理号CXSL2500071。奥辰生物(云南)有限公司,成立于2023年,位于昆明市,是一家以从事研究和试验发展为主的企业。主要股东信息显示,奥辰生物(云南)有限公司由奥辰干细胞再生医学工程(云南)有限公司持股100%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/21231549731389.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1141","BK1576","BK1583","03347"],"gpt_icon":0},{"id":"2529760805","title":"吉利德科學(GILD.O)宣佈Trodelvy(戈沙妥珠單抗)聯合Keytruda(帕博利珠單抗)在第三級臨牀試驗中達到","url":"https://stock-news.laohu8.com/highlight/detail?id=2529760805","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529760805?lang=zh_tw&edition=fundamental","pubTime":"2025-04-21 20:34","pubTimestamp":1745238866,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["GILD","LU1116320737.USD","SGXZ57979304.SGD","BK1583","LU1116320901.HKD","BK4568","LU1162221912.USD","LU1571399168.USD","BK4559","LU1291159041.SGD","IE00BJT1NW94.SGD","LU1069347547.HKD","LU2361044865.SGD","IE0009355771.USD","LU2361045086.USD","SG9999002224.SGD","LU1917777945.USD","LU2361044949.HKD","LU1093756168.USD","LU1989772923.USD","LU0965508806.USD","LU1989771016.USD","SG9999015341.SGD","LU0965509101.SGD","LU1430594728.SGD","LU0122379950.USD","BK4588","BK4585","LU1934455194.USD","MRK","BK4533","LU2106854487.HKD","IE00BFTCPJ56.SGD","SG9999014567.USD","LU0070302665.USD","IE00BBT3K403.USD","SG9999014542.SGD","LU2461242641.AUD","LU0965509283.SGD","LU1066053197.SGD","LU1066051811.HKD","LU1066051498.USD","LU1585245621.USD","SG9999015358.SGD","BK4532","03347","LU0320765646.SGD","LU0238689110.USD","LU0203345920.USD","LU0211331839.USD"],"gpt_icon":0},{"id":"2529871354","title":"科倫藥業:子公司SKB518新藥臨牀試驗申請獲FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2529871354","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529871354?lang=zh_tw&edition=fundamental","pubTime":"2025-04-21 18:41","pubTimestamp":1745232084,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["CDE","BK1583","002422","BK0239","LU1064130708.USD","LU1064131003.USD","IND.AU","BK4017","BK7095","BK4080","BK1576","03347","ADC","LU2148510915.USD","BK4231","BK0060","CDE.AU","ADC.AU","BK1141","BK7050"],"gpt_icon":0},{"id":"2529842879","title":"科倫博泰生物-B(06990):創新ADC藥物SKB518新藥臨牀試驗申請獲美國食品藥品監督管理局批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2529842879","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529842879?lang=zh_tw&edition=fundamental","pubTime":"2025-04-21 18:25","pubTimestamp":1745231131,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科伦博泰生物-B(06990)发布公告,公司已获得美国食品药品监督管理局(FDA)批准启动其创新抗体偶联药物(ADC)药物SKB518临床研究的新药临床试验(IND)申请。于2024年6月,公司收到国家药品监督管理局(NMPA)药品审评中心(CDE) 批准SKB518用于晚期实体瘤的IND申请的临床试验通知书。SKB518的1期临床试验正在中国进行中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1281560.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK4080","BK1576","ADC","BK4231","06990","BK1161","LU0196878994.USD","BK1583","03347"],"gpt_icon":0},{"id":"2529824524","title":"恆瑞醫藥:子公司收到藥物臨牀試驗批准通知書","url":"https://stock-news.laohu8.com/highlight/detail?id=2529824524","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529824524?lang=zh_tw&edition=fundamental","pubTime":"2025-04-21 16:57","pubTimestamp":1745225864,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0012","LU2328871848.SGD","BK0060","BK0188","LU1328615791.USD","161726","BK4023","LU1169590202.USD","LU1969619763.USD","LU1064131003.USD","09939","BK0183","LU2148510915.USD","BK1583","BK1576","BK1515","LU1169589451.USD","LU0405327494.USD","03347","LU0405327148.USD","LU1064130708.USD","PD","399441","159938","BK1161","BK1141","LU2488822045.USD","BK0028","600276","BK1574","BK0239","BK0196"],"gpt_icon":0},{"id":"2529288268","title":"【百奧泰:注射用BAT7111獲藥物臨牀試驗批准】百奧泰公告,公司於近日收到國家藥監局覈准簽發的《藥物臨牀試驗批准通知書》,公司在研藥品注射用BAT7111用於晚期實體瘤的臨牀試驗申請獲得批准。根據《Clinical Development Success Rates2011-2020》公佈的數據,通常情況下對於抗腫瘤藥物,一般I/II期臨牀研究階段持續約2年時間,I期完成進入II期的比率約48.8%,II期完成進入III期的比率約24.6%。考慮到臨牀研究週期長、投入大,過程中不可預測因素較多,臨牀試驗、審評和審批的結果以及時間都具有一定的不確定性。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529288268","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529288268?lang=zh_tw&edition=fundamental","pubTime":"2025-04-21 15:42","pubTimestamp":1745221338,"startTime":"0","endTime":"0","summary":"百奥泰公告,公司于近日收到国家药监局核准签发的《药物临床试验批准通知书》,公司在研药品注射用BAT7111用于晚期实体瘤的临床试验申请获得批准。根据《Clinical Development Success Rates2011-2020》公布的数据,通常情况下对于抗肿瘤药物,一般I/II期临床研究阶段持续约2年时间,I期完成进入II期的比率约48.8%,II期完成进入III期的比率约24.6%。考虑到临床研究周期长、投入大,过程中不可预测因素较多,临床试验、审评和审批的结果以及时间都具有一定的不确定性。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/21154249706014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["688177","BK0239","BK1583","BK4134","03347","III","BK1576","BK1141"],"gpt_icon":0},{"id":"2529427458","title":"中國人民銀行等四部門:加大對出口企業的保險支持力度","url":"https://stock-news.laohu8.com/highlight/detail?id=2529427458","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529427458?lang=zh_tw&edition=fundamental","pubTime":"2025-04-21 15:09","pubTimestamp":1745219381,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["159873","161726","399441","BK1141","159891","BK1576","03347","BK1583"],"gpt_icon":0},{"id":"2529844068","title":"晚期實體瘤藥物喜訊不斷,人福醫藥、匯宇製藥、翰森製藥等多藥企獲批臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2529844068","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529844068?lang=zh_tw&edition=fundamental","pubTime":"2025-04-21 14:21","pubTimestamp":1745216460,"startTime":"0","endTime":"0","summary":"多家药企在晚期实体瘤药物研发方面取得进展,人福医药、汇宇制药、翰森制药等新药获批临床试验,为治疗带来新希望。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042114361494dc8a64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042114361494dc8a64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","03347","BK1191","BK1583","03692","BK1141","BK1576"],"gpt_icon":0},{"id":"2528079331","title":"【改善患者肢體運動功能 “植入式迷走神經刺激系統”臨牀試驗啓動】今天,國家衞生健康委組織實施的“百萬減殘”工程重點推廣項目,我國自主研發的“植入式迷走神經刺激系統”臨牀試驗正式全國啓動。該項目有望成為我國卒中後殘疾防控的重要手段。","url":"https://stock-news.laohu8.com/highlight/detail?id=2528079331","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528079331?lang=zh_tw&edition=fundamental","pubTime":"2025-04-19 17:12","pubTimestamp":1745053922,"startTime":"0","endTime":"0","summary":"国家卫生健康委今天组织实施的“百万减残”工程重点推广项目,我国自主研发的“植入式迷走神经刺激系统”临床试验正式全国启动。该项目有望成为我国卒中后残疾防控的重要手段。迷走神经电刺激作为一种微创手术,可以辅助脑卒中患者康复治疗。数据显示,该技术能够在卒中后康复黄金期6月以后,帮助患者持续重建神经功能,明显改善患侧肢体运动功能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/19171249689081.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1576","BK1141","BK1583","03347"],"gpt_icon":0},{"id":"2528064691","title":"Sands Capital Management,LP減持泰格醫藥(03347)38.41萬股 每股作價為25.9329港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528064691","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528064691?lang=zh_tw&edition=fundamental","pubTime":"2025-04-18 21:17","pubTimestamp":1744982239,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,4月15日,Sands Capital Management,LP减持泰格医药(03347)38.41万股,每股作价为25.9329港元,总金额约为996.08万港元。减持后最新持股数目为1089.6493万股,持股比例为8.85%。本交易涉及其他关联方:Sands Capital Management,LLC;Sands Family Trust, LLC;Sands Frank Melville Jr.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1280972.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4130","BK1583","BK0028","FVRR","LU1146622755.USD","BK0077","BK4585","BK1141","BK0174","BK1576","300347","03347","BK4588","BK0216","BK4122","LU1820825898.SGD"],"gpt_icon":0},{"id":"2528681880","title":"【沃森生物:20價肺炎球菌多糖結合疫苗獲臨牀試驗批准】沃森生物公告,公司及子公司共同申請的20價肺炎球菌多糖結合疫苗獲得國家藥品監督管理局簽發的《藥物臨牀試驗批准通知書》,通知書編號為2025LP01099。該疫苗是在已上市產品13價肺炎球菌多糖結合疫苗基礎上開發的迭代升級產品,新增了8型、10A型、11A型、12F型、15B型、22F型和33F型共計7種血清型,用於預防由本品所含20種肺炎球菌血清型引起的感染性疾病。全球已上市20價肺炎球菌多糖結合疫苗的廠家僅有美國輝瑞公司一家,國內尚未有20價肺炎球菌多糖結合疫苗上市銷售。","url":"https://stock-news.laohu8.com/highlight/detail?id=2528681880","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528681880?lang=zh_tw&edition=fundamental","pubTime":"2025-04-18 19:21","pubTimestamp":1744975312,"startTime":"0","endTime":"0","summary":"沃森生物公告,公司及子公司共同申请的20价肺炎球菌多糖结合疫苗获得国家药品监督管理局签发的《药物临床试验批准通知书》,通知书编号为2025LP01099。该疫苗是在已上市产品13价肺炎球菌多糖结合疫苗基础上开发的迭代升级产品,新增了8型、10A型、11A型、12F型、15B型、22F型和33F型共计7种血清型,用于预防由本品所含20种肺炎球菌血清型引起的感染性疾病。全球已上市20价肺炎球菌多糖结合疫苗的厂家仅有美国辉瑞公司一家,国内尚未有20价肺炎球菌多糖结合疫苗上市销售。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/18192149669574.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4592","IE00BLSP4239.USD","SG9999013999.USD","LU0234572021.USD","SG9999011175.SGD","03347","LU0456855351.SGD","LU0306806265.USD","BK4534","LU1894683264.USD","SG9999003800.SGD","SGXZ57979304.SGD","300142","LU0321505439.SGD","BK4581","IE0002270589.USD","LU0225284248.USD","IE00B19Z3B42.SGD","BK4550","LU0985481810.HKD","SG9999001176.USD","IE00BBT3K403.USD","LU0225771236.USD","IE000M9KFDE8.USD","LU0170899867.USD","LU1066051498.USD","LU0058720904.USD","BK4599","BK4585","LU1023059063.AUD","SG9999001176.SGD","IE00BLSP4452.SGD","LU0289739699.SGD","BK0239","159646","SG9999002224.SGD","BK1576","SG9999002232.USD","BK0077","LU0306807586.USD","BK4568","BK0070","BK4533","LU1894683348.USD","LU1883839398.USD","BK1141","BK4007","LU1057294990.SGD","LU1066053197.SGD"],"gpt_icon":0},{"id":"2528872920","title":"盛禾(中國)生物製藥有限公司藥品申請臨牀試驗默示許可獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2528872920","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528872920?lang=zh_tw&edition=fundamental","pubTime":"2025-04-18 13:40","pubTimestamp":1744954838,"startTime":"0","endTime":"0","summary":"4月18日,据CDE官网消息,盛禾(中国)生物制药有限公司联合申请药品“IAH0968”,获得临床试验默示许可,受理号CXSL2500141。盛禾(中国)生物制药有限公司,成立于2018年,位于南京市,是一家以从事医药制造业为主的企业。主要股东信息显示,盛禾(中国)生物制药有限公司由盛禾医药科技有限公司持股100%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/18134049650526.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1141","03347","BK1576","BK1583"],"gpt_icon":0},{"id":"2528308722","title":"石藥集團歐意藥業有限公司藥品申請臨牀試驗默示許可獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2528308722","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528308722?lang=zh_tw&edition=fundamental","pubTime":"2025-04-18 13:40","pubTimestamp":1744954838,"startTime":"0","endTime":"0","summary":"4月18日,据CDE官网消息,石药集团欧意药业有限公司联合申请药品“普卢格列汀二甲双胍缓释片(Ⅰ)”,获得临床试验默示许可,受理号CXHL2500185。通过天眼查大数据分析,石药集团欧意药业有限公司共对外投资了11家企业,参与招投标项目5000次,知识产权方面有商标信息198条,专利信息197条,此外企业还拥有行政许可746个。主要股东信息显示,石药集团欧意药业有限公司由石药集团恩必普药业有限公司持股100%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/18134049650524.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IE00B5MMRT66.SGD","LU1226288253.USD","LU1008478684.HKD","IE0008369823.USD","IE00BZ08YS42.EUR","LU1226288170.HKD","LU0072913022.USD","LU0326950275.SGD","LU1152091168.USD","LU1960683339.HKD","IE00BZ08YT58.USD","IE00B031HY20.USD","LU1993786604.SGD","BK1141","IE00BZ08YR35.GBP","LU1226287875.USD","LU0067412154.USD","LU0140636845.USD","LU1807302812.USD","BK1191","BK1583","IE0008368742.USD","LU0880133367.SGD","BK1521","LU0501845795.SGD","03347","BK1576","LU1226287792.SGD","01093","IE00B543WZ88.USD","LU1226287529.USD","SG9999004220.SGD","BK1515","LU1951186391.HKD","LU1152091754.HKD"],"gpt_icon":0},{"id":"2528208778","title":"普方生物製藥(蘇州)有限公司藥品申請臨牀試驗默示許可獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2528208778","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528208778?lang=zh_tw&edition=fundamental","pubTime":"2025-04-18 13:40","pubTimestamp":1744954838,"startTime":"0","endTime":"0","summary":"4月18日,据CDE官网消息,普方生物制药(苏州)有限公司联合申请药品“注射用GEN1184”,获得临床试验默示许可,受理号CXSB2500023。普方生物制药(苏州)有限公司,成立于2019年,位于苏州市,是一家以从事研究和试验发展为主的企业。主要股东信息显示,普方生物制药(苏州)有限公司由ProfoundBio Limited持股100%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/18134049650527.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["03347","BK1141","BK1576","BK1583"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/03347\",params:#limit:5,,,undefined,":[{"date":"2025-04-28","symbol":"03347","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1745803800000,"name":null,"time":"","dateTimestamp":1745769600000,"actualEps":null},{"market":"HK","date":"2025-03-27","symbol":"03347","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1743004800000,"reportTimeType":"","actualEps":null},{"date":"2024-10-29","symbol":"03347","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1730165400000,"name":null,"time":"","dateTimestamp":1730131200000,"actualEps":null},{"date":"2024-08-28","symbol":"03347","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724808600000,"name":null,"time":"","dateTimestamp":1724774400000,"actualEps":null},{"date":"2024-06-07","symbol":"03347","amount":0.62365,"announcedDate":null,"type":"dividend","lastAmount":0.61193,"market":"HK","newRecordDate":"2024-06-11","name":"泰格医药","lastCurrency":"HKD","lastExecuteDate":"2023-05-25","recordDate":"2024-07-31","payableDate":"2024-06-11","currency":"HKD","dateTimestamp":1717689600000,"payDate":"2024-07-31"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"03347\",market:\"HK\",,,undefined,":[{"executeDate":"2021-05-25","recordDate":"2021-05-26","paymentDate":"2021-06-21","value":0.3,"currency":"CNY"},{"executeDate":"2022-05-24","recordDate":"2022-05-26","paymentDate":"2022-06-20","value":0.58625,"currency":"HKD"},{"executeDate":"2023-05-25","recordDate":"2023-05-30","paymentDate":"2023-05-29","value":0.61193,"currency":"HKD"},{"executeDate":"2024-06-07","recordDate":"2024-06-11","paymentDate":"2024-07-31","value":0.62365,"currency":"HKD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"03347\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.4,"hold":0.2,"sell":0.1,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4,"analysts":10,"updateTime":1731081600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/03347\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"03347","date":"2025-04-25","current":89.034454,"percent":0.958927,"low":13.490363,"twenty":24.185833,"median":36.09533,"eighty":68.310143,"high":105.594891,"avg":45.073485,"sd":23.054789,"marketCap":38397675392.47},"quantilePoints":[{"date":"2020-04-29","current":60.230946,"twenty":103.889794,"median":120.402323,"eighty":147.661343,"marketCap":62740871824.28},{"date":"2020-05-08","current":61.310579,"twenty":101.401003,"median":120.23037,"eighty":147.529523,"marketCap":63898366512.41},{"date":"2020-05-15","current":64.024918,"twenty":100.35517,"median":120.033351,"eighty":147.529523,"marketCap":66463570230.76},{"date":"2020-05-22","current":62.56712,"twenty":99.662945,"median":119.439377,"eighty":147.529523,"marketCap":64741513423.58},{"date":"2020-05-29","current":66.861714,"twenty":99.270521,"median":119.439377,"eighty":147.529523,"marketCap":69075681319.66},{"date":"2020-06-05","current":66.759274,"twenty":98.696894,"median":119.263332,"eighty":147.348788,"marketCap":69472773860.17},{"date":"2020-06-12","current":67.602433,"twenty":97.774537,"median":118.746325,"eighty":146.592375,"marketCap":70343524337.3},{"date":"2020-06-19","current":70.998709,"twenty":97.239517,"median":118.613997,"eighty":146.409575,"marketCap":74012194596.27},{"date":"2020-06-26","current":76.924461,"twenty":96.75698,"median":118.296332,"eighty":146.21398,"marketCap":80116852533.24},{"date":"2020-07-03","current":76.089183,"twenty":96.486993,"median":118.212747,"eighty":146.014113,"marketCap":79369035956.25},{"date":"2020-07-10","current":83.772173,"twenty":96.302769,"median":117.985195,"eighty":145.612626,"marketCap":88216502654.67},{"date":"2020-07-17","current":84.899011,"twenty":96.066617,"median":117.751955,"eighty":144.71517,"marketCap":89545174572.35},{"date":"2020-07-24","current":82.732014,"twenty":95.158773,"median":117.679704,"eighty":144.465516,"marketCap":86918045940.35},{"date":"2020-07-31","current":84.867491,"twenty":94.627113,"median":117.4791,"eighty":144.357702,"marketCap":89684950346.2},{"date":"2020-08-07","current":96.318243,"twenty":94.122409,"median":117.296665,"eighty":144.204769,"marketCap":101895508042.15},{"date":"2020-08-14","current":90.303016,"twenty":93.941564,"median":117.117995,"eighty":143.975033,"marketCap":95771591703.53},{"date":"2020-08-21","current":92.400458,"twenty":92.954045,"median":116.92885,"eighty":143.492819,"marketCap":98440671657.19},{"date":"2020-08-28","current":105.025609,"twenty":93.041259,"median":116.619332,"eighty":143.361076,"marketCap":112764546838.05},{"date":"2020-09-04","current":62.920186,"twenty":92.634525,"median":116.453215,"eighty":143.264119,"marketCap":106075006841.68},{"date":"2020-09-11","current":58.569062,"twenty":92.364339,"median":116.344425,"eighty":143.184047,"marketCap":98845394189.36},{"date":"2020-09-18","current":57.461927,"twenty":91.085228,"median":116.274746,"eighty":142.954832,"marketCap":97917077106.27},{"date":"2020-09-25","current":58.723218,"twenty":90.719149,"median":116.198192,"eighty":142.385569,"marketCap":99271356008.09},{"date":"2020-09-30","current":59.84386,"twenty":90.558848,"median":116.0827,"eighty":142.234714,"marketCap":101648343737.58},{"date":"2020-10-09","current":62.956316,"twenty":90.279083,"median":115.828339,"eighty":142.168805,"marketCap":108474629252.57},{"date":"2020-10-16","current":66.708337,"twenty":89.806115,"median":115.689222,"eighty":142.088245,"marketCap":114892250417.07},{"date":"2020-10-23","current":66.68348,"twenty":89.501976,"median":115.108814,"eighty":141.907905,"marketCap":115027470218.9},{"date":"2020-10-30","current":65.058183,"twenty":89.055674,"median":115.002959,"eighty":141.695464,"marketCap":123041176160.73},{"date":"2020-11-06","current":64.831627,"twenty":88.624748,"median":114.944215,"eighty":141.604613,"marketCap":124046342028.73},{"date":"2020-11-13","current":66.330986,"twenty":88.331644,"median":114.78648,"eighty":141.414427,"marketCap":127021763049.96},{"date":"2020-11-20","current":63.199998,"twenty":87.873239,"median":114.588887,"eighty":141.302299,"marketCap":121784996092.84},{"date":"2020-11-27","current":60.755153,"twenty":87.48172,"median":114.324027,"eighty":141.08888,"marketCap":116800212350.29},{"date":"2020-12-04","current":69.132377,"twenty":86.777772,"median":114.169764,"eighty":140.802361,"marketCap":133861503404.14},{"date":"2020-12-11","current":73.306289,"twenty":86.272991,"median":114.042903,"eighty":140.565984,"marketCap":141603844025.95},{"date":"2020-12-18","current":79.625725,"twenty":85.132259,"median":113.930453,"eighty":140.544495,"marketCap":154060297802.71},{"date":"2020-12-24","current":84.330076,"twenty":84.660186,"median":113.855486,"eighty":140.211472,"marketCap":163330600385.07},{"date":"2020-12-31","current":85.626424,"twenty":84.79257,"median":113.805349,"eighty":139.899572,"marketCap":165909321175.35},{"date":"2021-01-08","current":87.626604,"twenty":86.569405,"median":87.647987,"eighty":89.321516,"marketCap":171313888262.75},{"date":"2021-01-15","current":86.004174,"twenty":85.969089,"median":87.143346,"eighty":88.331219,"marketCap":167903377831.91},{"date":"2021-01-22","current":96.398854,"twenty":85.885534,"median":87.308059,"eighty":90.457868,"marketCap":188117400486.35},{"date":"2021-01-29","current":87.557455,"twenty":85.969089,"median":87.606958,"eighty":91.438993,"marketCap":172276438660.15},{"date":"2021-02-05","current":94.847004,"twenty":86.254161,"median":87.961753,"eighty":93.529174,"marketCap":185501406822.67},{"date":"2021-02-11","current":99.124589,"twenty":86.519877,"median":89.273358,"eighty":95.849858,"marketCap":194145434216.88},{"date":"2021-02-19","current":95.495509,"twenty":86.730497,"median":91.181174,"eighty":96.327859,"marketCap":187119112235.66},{"date":"2021-02-26","current":74.127654,"twenty":85.934004,"median":89.079388,"eighty":95.946868,"marketCap":144930523901.81},{"date":"2021-03-05","current":73.598461,"twenty":84.704073,"median":87.647987,"eighty":95.546166,"marketCap":143535146538.52},{"date":"2021-03-12","current":70.645259,"twenty":77.620038,"median":87.572384,"eighty":95.365808,"marketCap":137534472295.22},{"date":"2021-03-19","current":69.764567,"twenty":73.7043,"median":86.978633,"eighty":94.602378,"marketCap":135774716632.37},{"date":"2021-03-26","current":74.142296,"twenty":70.647334,"median":86.544641,"eighty":93.616029,"marketCap":143657571005.52},{"date":"2021-04-01","current":74.721348,"twenty":70.655634,"median":85.960318,"eighty":93.584655,"marketCap":154865167289.03},{"date":"2021-04-09","current":69.248878,"twenty":70.651484,"median":85.839142,"eighty":93.513487,"marketCap":143839884168.43},{"date":"2021-04-16","current":65.336796,"twenty":69.668455,"median":85.049954,"eighty":92.898727,"marketCap":136227777457.36},{"date":"2021-04-23","current":75.537259,"twenty":69.668455,"median":80.028377,"eighty":92.23468,"marketCap":157890024706.8},{"date":"2021-04-30","current":68.167178,"twenty":69.595052,"median":77.008813,"eighty":91.913081,"marketCap":159467986405.02},{"date":"2021-05-07","current":63.281183,"twenty":68.19046,"median":74.842614,"eighty":91.438993,"marketCap":148997052047.51},{"date":"2021-05-14","current":67.823728,"twenty":68.043757,"median":74.262644,"eighty":90.457868,"marketCap":159588623092.11},{"date":"2021-05-21","current":76.44953,"twenty":68.113042,"median":74.134975,"eighty":89.694742,"marketCap":179934635673.8},{"date":"2021-05-28","current":74.019036,"twenty":68.174401,"median":74.382992,"eighty":89.118182,"marketCap":175930736659.65},{"date":"2021-06-04","current":80.32759,"twenty":68.188718,"median":74.940752,"eighty":88.515952,"marketCap":190019976315.5},{"date":"2021-06-11","current":79.160219,"twenty":68.215346,"median":75.588409,"eighty":87.836247,"marketCap":187244817982.85},{"date":"2021-06-18","current":79.747269,"twenty":68.257693,"median":76.44953,"eighty":87.64371,"marketCap":187103692929.56},{"date":"2021-06-25","current":84.348015,"twenty":68.488697,"median":76.875616,"eighty":87.618746,"marketCap":197773446315.54},{"date":"2021-07-02","current":83.427162,"twenty":69.248878,"median":77.248978,"eighty":87.587313,"marketCap":195272477805.36},{"date":"2021-07-09","current":68.898442,"twenty":68.898442,"median":76.989936,"eighty":87.557455,"marketCap":161104474635.59},{"date":"2021-07-16","current":76.64457,"twenty":69.248878,"median":77.0208,"eighty":87.308059,"marketCap":179213470976},{"date":"2021-07-23","current":71.242396,"twenty":69.524287,"median":76.64457,"eighty":86.978633,"marketCap":166565860976.47},{"date":"2021-07-30","current":68.457404,"twenty":68.898442,"median":76.424527,"eighty":86.831502,"marketCap":160592266192.07},{"date":"2021-08-06","current":73.890201,"twenty":68.898442,"median":75.588409,"eighty":86.668463,"marketCap":172918339749.39},{"date":"2021-08-13","current":68.312418,"twenty":68.457404,"median":75.349394,"eighty":86.420819,"marketCap":160082987331.64},{"date":"2021-08-20","current":59.053724,"twenty":68.247453,"median":74.842614,"eighty":86.004174,"marketCap":137994045627.59},{"date":"2021-08-27","current":57.990082,"twenty":68.076952,"median":74.55217,"eighty":85.916462,"marketCap":139989605903.33},{"date":"2021-09-03","current":55.037591,"twenty":67.722205,"median":74.127654,"eighty":85.839142,"marketCap":132916202307.47},{"date":"2021-09-10","current":63.783012,"twenty":67.050525,"median":73.954619,"eighty":85.826108,"marketCap":154432623789.65},{"date":"2021-09-17","current":72.748957,"twenty":66.976665,"median":73.494908,"eighty":85.626424,"marketCap":175620186122.47},{"date":"2021-09-24","current":70.965801,"twenty":67.035753,"median":73.259845,"eighty":84.984318,"marketCap":171394803510.39},{"date":"2021-09-30","current":72.477627,"twenty":67.140142,"median":73.033313,"eighty":84.71,"marketCap":175631927175.09},{"date":"2021-10-08","current":71.958357,"twenty":67.225571,"median":72.771338,"eighty":84.537747,"marketCap":174365645457.75},{"date":"2021-10-15","current":69.08908,"twenty":67.348209,"median":72.74879,"eighty":84.423297,"marketCap":167527800392.83},{"date":"2021-10-22","current":61.617651,"twenty":67.348209,"median":72.731409,"eighty":84.285229,"marketCap":166001923046.33},{"date":"2021-10-29","current":63.769484,"twenty":66.84704,"median":72.486191,"eighty":84.117296,"marketCap":171374289912.14},{"date":"2021-11-05","current":54.541711,"twenty":66.541242,"median":72.289224,"eighty":83.933333,"marketCap":146817072839.41},{"date":"2021-11-12","current":53.605833,"twenty":66.129375,"median":72.076363,"eighty":83.7987,"marketCap":144892777467.6},{"date":"2021-11-19","current":53.467669,"twenty":65.353973,"median":71.577518,"eighty":83.627913,"marketCap":144314832117.59},{"date":"2021-11-26","current":52.902947,"twenty":64.061666,"median":71.500426,"eighty":83.183722,"marketCap":142836284475.75},{"date":"2021-12-03","current":50.941496,"twenty":63.382045,"median":71.242396,"eighty":82.180084,"marketCap":137794722766.58},{"date":"2021-12-10","current":53.063954,"twenty":62.461775,"median":70.955694,"eighty":81.002583,"marketCap":143780972201.86},{"date":"2021-12-17","current":48.210318,"twenty":61.171173,"median":70.851376,"eighty":80.534779,"marketCap":130539365754.14},{"date":"2021-12-24","current":43.814045,"twenty":60.453189,"median":70.708628,"eighty":80.224038,"marketCap":118748853123.13},{"date":"2021-12-31","current":47.087839,"twenty":59.257324,"median":70.650447,"eighty":80.060644,"marketCap":127899394040},{"date":"2022-01-07","current":33.412439,"twenty":68.634148,"median":99.553378,"eighty":131.458276,"marketCap":90409872642},{"date":"2022-01-14","current":37.081439,"twenty":68.517976,"median":99.349368,"eighty":131.440369,"marketCap":100556256397},{"date":"2022-01-21","current":35.123637,"twenty":68.308627,"median":99.107528,"eighty":131.435003,"marketCap":95465200382},{"date":"2022-01-28","current":31.033038,"twenty":68.193942,"median":98.959652,"eighty":131.310652,"marketCap":84131763305},{"date":"2022-02-04","current":31.086802,"twenty":68.174401,"median":98.959652,"eighty":131.310652,"marketCap":84236210073},{"date":"2022-02-11","current":26.787152,"twenty":67.801697,"median":98.706882,"eighty":131.262257,"marketCap":72732015499},{"date":"2022-02-18","current":30.78566,"twenty":67.577627,"median":98.299094,"eighty":131.189665,"marketCap":83999228453},{"date":"2022-02-25","current":31.466714,"twenty":67.326634,"median":97.540023,"eighty":131.189665,"marketCap":86069166504},{"date":"2022-03-04","current":28.86193,"twenty":67.099621,"median":97.405312,"eighty":131.189665,"marketCap":78974686047},{"date":"2022-03-11","current":27.659609,"twenty":66.801059,"median":96.990822,"eighty":131.189665,"marketCap":75570508661},{"date":"2022-03-18","current":22.079002,"twenty":66.693423,"median":96.75698,"eighty":131.130292,"marketCap":78040315580},{"date":"2022-03-25","current":23.082123,"twenty":66.49468,"median":96.546401,"eighty":130.974914,"marketCap":81589357799},{"date":"2022-04-01","current":24.437166,"twenty":66.313421,"median":96.398854,"eighty":130.813092,"marketCap":86766253383},{"date":"2022-04-08","current":23.584999,"twenty":66.213923,"median":96.369086,"eighty":130.665206,"marketCap":83539464208},{"date":"2022-04-14","current":23.65417,"twenty":66.113115,"median":96.318243,"eighty":130.447734,"marketCap":83691576091},{"date":"2022-04-22","current":22.824055,"twenty":66.001142,"median":96.286187,"eighty":130.417596,"marketCap":79166547004},{"date":"2022-04-29","current":21.371665,"twenty":65.916599,"median":96.162803,"eighty":130.231493,"marketCap":74532865898},{"date":"2022-05-06","current":19.696234,"twenty":65.686332,"median":95.979703,"eighty":129.978267,"marketCap":68119284085},{"date":"2022-05-13","current":21.648474,"twenty":65.526728,"median":95.486721,"eighty":129.764603,"marketCap":73531463992},{"date":"2022-05-20","current":21.58617,"twenty":65.310876,"median":95.187787,"eighty":129.594162,"marketCap":74348580992},{"date":"2022-05-27","current":19.957113,"twenty":65.004796,"median":94.924136,"eighty":129.420413,"marketCap":68678040034},{"date":"2022-06-02","current":19.71246,"twenty":64.822963,"median":94.726769,"eighty":129.29148,"marketCap":68200201389},{"date":"2022-06-10","current":23.148454,"twenty":64.603309,"median":94.436737,"eighty":129.270351,"marketCap":79733744533},{"date":"2022-06-17","current":23.587125,"twenty":64.311531,"median":94.225759,"eighty":129.130631,"marketCap":80968080347},{"date":"2022-06-24","current":25.22544,"twenty":63.845455,"median":93.941564,"eighty":128.905033,"marketCap":86936718197},{"date":"2022-06-30","current":27.449146,"twenty":63.469678,"median":93.941564,"eighty":128.885882,"marketCap":94437606027},{"date":"2022-07-08","current":28.797811,"twenty":63.199998,"median":93.363224,"eighty":128.616462,"marketCap":99179620092},{"date":"2022-07-15","current":28.423417,"twenty":62.956184,"median":93.053159,"eighty":128.492114,"marketCap":96983003500},{"date":"2022-07-22","current":26.666941,"twenty":62.312205,"median":92.737855,"eighty":128.455017,"marketCap":91049455757},{"date":"2022-07-29","current":24.660249,"twenty":61.595401,"median":92.617944,"eighty":128.277827,"marketCap":84266401668},{"date":"2022-08-05","current":25.723543,"twenty":61.271176,"median":92.569231,"eighty":128.24342,"marketCap":87711547893},{"date":"2022-09-23","current":23.033086,"twenty":60.78939,"median":92.400458,"eighty":127.995817,"marketCap":71808024242},{"date":"2022-09-30","current":24.117634,"twenty":60.680136,"median":91.873987,"eighty":127.735126,"marketCap":74741958229},{"date":"2022-10-07","current":24.04288,"twenty":60.44433,"median":91.223216,"eighty":127.638829,"marketCap":74580556354},{"date":"2022-10-14","current":23.920689,"twenty":60.232428,"median":90.829042,"eighty":127.546242,"marketCap":73604064828},{"date":"2022-10-21","current":22.90546,"twenty":59.882701,"median":90.699852,"eighty":127.480595,"marketCap":70068574996},{"date":"2022-10-28","current":23.93619,"twenty":58.959507,"median":90.546086,"eighty":127.479003,"marketCap":70139309633},{"date":"2022-11-04","current":26.804341,"twenty":58.326952,"median":90.233764,"eighty":127.479003,"marketCap":77753543362},{"date":"2022-11-11","current":26.598918,"twenty":57.502848,"median":89.633611,"eighty":127.479003,"marketCap":78102717984},{"date":"2022-11-18","current":27.491771,"twenty":56.8504,"median":89.273358,"eighty":127.479003,"marketCap":81115538827},{"date":"2022-11-25","current":25.532825,"twenty":49.806467,"median":88.618366,"eighty":127.479003,"marketCap":75233085101},{"date":"2022-12-02","current":25.996273,"twenty":46.584625,"median":88.263767,"eighty":127.479003,"marketCap":77454399373},{"date":"2022-12-09","current":25.286101,"twenty":44.41679,"median":87.84385,"eighty":127.479003,"marketCap":76226777077},{"date":"2022-12-16","current":25.796026,"twenty":43.834351,"median":87.561159,"eighty":127.480595,"marketCap":77599617858},{"date":"2022-12-23","current":26.995642,"twenty":43.433468,"median":87.292084,"eighty":127.480595,"marketCap":81332297224},{"date":"2022-12-30","current":29.025903,"twenty":42.84823,"median":86.831502,"eighty":127.480595,"marketCap":87663426719},{"date":"2023-01-06","current":30.036105,"twenty":42.355551,"median":86.545656,"eighty":127.480595,"marketCap":91975094534},{"date":"2023-01-13","current":31.054347,"twenty":41.583446,"median":86.116422,"eighty":127.480595,"marketCap":97115158878},{"date":"2023-01-20","current":33.085706,"twenty":39.332255,"median":85.721473,"eighty":127.480595,"marketCap":103166818782},{"date":"2023-01-27","current":33.275238,"twenty":38.224178,"median":84.867491,"eighty":127.480595,"marketCap":103612461509},{"date":"2023-02-03","current":31.549188,"twenty":37.134484,"median":84.473485,"eighty":126.842685,"marketCap":99208451089},{"date":"2023-02-10","current":32.634729,"twenty":36.602044,"median":84.260564,"eighty":126.847691,"marketCap":101925371775},{"date":"2023-02-17","current":35.077173,"twenty":36.122656,"median":83.823336,"eighty":126.842685,"marketCap":108286977020.71},{"date":"2023-02-24","current":34.44985,"twenty":35.783497,"median":83.167352,"eighty":125.947463,"marketCap":105579305687},{"date":"2023-03-03","current":34.915794,"twenty":35.285763,"median":82.267095,"eighty":125.364204,"marketCap":106969098907.3},{"date":"2023-03-10","current":33.573669,"twenty":33.09093,"median":33.271957,"eighty":33.452984,"marketCap":102098132624.56},{"date":"2023-03-17","current":30.874895,"twenty":35.074915,"median":66.887634,"eighty":81.424751,"marketCap":94799549765.75},{"date":"2023-03-24","current":32.465176,"twenty":34.912016,"median":66.733981,"eighty":81.424751,"marketCap":100826887012.98},{"date":"2023-03-31","current":39.409949,"twenty":34.683056,"median":66.61301,"eighty":80.883119,"marketCap":90339903001.34},{"date":"2023-04-06","current":40.01943,"twenty":34.717331,"median":66.568574,"eighty":80.672905,"marketCap":91677850830.55},{"date":"2023-04-14","current":43.501612,"twenty":34.648782,"median":66.409404,"eighty":80.327836,"marketCap":99753351324.46},{"date":"2023-04-21","current":39.684255,"twenty":34.648782,"median":66.286213,"eighty":79.930036,"marketCap":90952979932.48},{"date":"2023-04-28","current":36.304911,"twenty":34.648782,"median":66.171142,"eighty":79.599218,"marketCap":84647789074.03},{"date":"2023-05-05","current":35.266346,"twenty":34.648782,"median":66.078095,"eighty":79.391755,"marketCap":82361126820.09},{"date":"2023-05-12","current":35.675725,"twenty":34.530606,"median":65.955814,"eighty":79.307272,"marketCap":82743463772.61},{"date":"2023-05-19","current":35.805573,"twenty":34.530606,"median":65.753076,"eighty":79.307272,"marketCap":81876875937.13},{"date":"2023-05-25","current":34.646396,"twenty":34.538282,"median":65.674629,"eighty":79.28877,"marketCap":78900164667.33},{"date":"2023-06-02","current":32.806859,"twenty":33.850727,"median":65.523354,"eighty":79.253595,"marketCap":74457647045.07},{"date":"2023-06-09","current":28.614704,"twenty":33.42886,"median":65.358268,"eighty":79.008587,"marketCap":64849539142.86},{"date":"2023-06-16","current":29.286074,"twenty":33.160363,"median":65.192058,"eighty":78.327061,"marketCap":66053206160.21},{"date":"2023-06-23","current":26.253583,"twenty":32.852519,"median":65.123944,"eighty":78.139484,"marketCap":58890615712.37},{"date":"2023-06-30","current":25.798294,"twenty":32.576847,"median":64.898154,"eighty":77.785789,"marketCap":57345863691.42},{"date":"2023-07-07","current":25.12591,"twenty":31.980613,"median":64.752273,"eighty":77.572567,"marketCap":55742295932.75},{"date":"2023-07-14","current":25.973911,"twenty":31.692772,"median":64.600157,"eighty":77.002282,"marketCap":58432199629.55},{"date":"2023-07-21","current":25.436832,"twenty":31.458975,"median":64.516711,"eighty":76.872052,"marketCap":56958008811.62},{"date":"2023-07-28","current":27.09077,"twenty":31.050085,"median":64.198278,"eighty":76.769176,"marketCap":60596567128.72},{"date":"2023-08-04","current":27.007399,"twenty":30.828153,"median":63.985407,"eighty":76.487474,"marketCap":60510502653.38},{"date":"2023-08-11","current":27.522447,"twenty":30.613346,"median":63.783012,"eighty":76.364042,"marketCap":61316297506.33},{"date":"2023-08-18","current":25.037031,"twenty":30.102301,"median":63.649904,"eighty":76.233066,"marketCap":55379761099.96},{"date":"2023-08-25","current":24.014939,"twenty":29.796106,"median":63.318713,"eighty":76.233066,"marketCap":56925667849.27},{"date":"2023-09-01","current":24.354537,"twenty":29.639594,"median":63.024159,"eighty":76.233066,"marketCap":57970356547.96},{"date":"2023-09-08","current":22.978329,"twenty":29.277231,"median":62.920186,"eighty":76.233066,"marketCap":54050714390.12},{"date":"2023-09-15","current":23.575471,"twenty":29.06469,"median":62.859364,"eighty":76.233066,"marketCap":55885320461.83},{"date":"2023-09-22","current":24.032194,"twenty":28.705314,"median":62.675351,"eighty":76.233066,"marketCap":56718895697.61},{"date":"2023-09-29","current":24.610939,"twenty":28.423417,"median":62.095386,"eighty":76.231368,"marketCap":58184420744.27},{"date":"2023-10-06","current":24.51557,"twenty":28.061406,"median":61.606526,"eighty":76.231368,"marketCap":57931198627.72},{"date":"2023-10-13","current":26.587571,"twenty":27.677263,"median":61.547949,"eighty":76.231368,"marketCap":62733562289.52},{"date":"2023-10-20","current":23.939753,"twenty":27.566042,"median":61.541021,"eighty":76.221571,"marketCap":56398986556.88},{"date":"2023-10-27","current":21.974644,"twenty":27.449146,"median":61.547949,"eighty":76.231368,"marketCap":53593896199.95},{"date":"2023-11-03","current":24.200229,"twenty":27.073114,"median":61.547949,"eighty":76.231368,"marketCap":59178586653.11},{"date":"2023-11-10","current":25.091257,"twenty":26.938319,"median":61.547949,"eighty":76.231368,"marketCap":61344660506.68},{"date":"2023-11-17","current":24.260541,"twenty":26.744215,"median":61.547949,"eighty":76.231368,"marketCap":59848622500.32},{"date":"2023-11-24","current":22.814302,"twenty":26.651268,"median":61.547949,"eighty":76.231368,"marketCap":56744217036.84},{"date":"2023-12-01","current":22.313216,"twenty":26.572732,"median":61.547949,"eighty":76.231368,"marketCap":55728030473.49},{"date":"2023-12-08","current":20.009126,"twenty":26.433909,"median":61.547949,"eighty":76.231368,"marketCap":49771504315.1},{"date":"2023-12-15","current":19.224268,"twenty":26.327895,"median":61.547949,"eighty":76.231368,"marketCap":48095352490.46},{"date":"2023-12-22","current":19.081376,"twenty":26.097181,"median":61.547949,"eighty":76.231368,"marketCap":47705979617.18},{"date":"2023-12-29","current":19.63918,"twenty":26.058994,"median":61.547949,"eighty":76.231368,"marketCap":49362361152.21},{"date":"2024-01-05","current":17.806824,"twenty":25.996273,"median":61.547949,"eighty":76.231368,"marketCap":44441150697.99},{"date":"2024-01-12","current":17.910322,"twenty":25.85676,"median":61.547949,"eighty":76.231368,"marketCap":44723249783.07},{"date":"2024-01-19","current":17.399027,"twenty":25.798294,"median":61.547949,"eighty":76.231368,"marketCap":43386836742.1},{"date":"2024-01-26","current":15.630474,"twenty":25.6815,"median":61.547949,"eighty":76.231368,"marketCap":38825016330.62},{"date":"2024-02-02","current":13.72567,"twenty":25.552885,"median":61.547949,"eighty":76.231368,"marketCap":34050147995.97},{"date":"2024-02-09","current":15.155401,"twenty":25.497859,"median":61.351171,"eighty":76.201977,"marketCap":37782127799.3},{"date":"2024-02-16","current":15.211925,"twenty":25.436832,"median":61.541021,"eighty":76.221571,"marketCap":37931239068.87},{"date":"2024-02-23","current":15.629427,"twenty":25.404935,"median":61.541021,"eighty":76.221571,"marketCap":38766841756.31},{"date":"2024-03-01","current":16.076593,"twenty":25.372603,"median":61.329942,"eighty":76.211774,"marketCap":39900850659.5},{"date":"2024-03-08","current":14.747114,"twenty":25.238272,"median":61.055764,"eighty":76.211774,"marketCap":36617463905.46},{"date":"2024-03-15","current":18.538831,"twenty":25.127033,"median":60.735247,"eighty":76.211774,"marketCap":45991648849.54},{"date":"2024-03-22","current":17.089834,"twenty":25.077345,"median":60.649939,"eighty":76.211774,"marketCap":42358154807.71},{"date":"2024-03-28","current":18.496555,"twenty":24.916219,"median":60.416344,"eighty":76.211774,"marketCap":45698167212.2},{"date":"2024-04-05","current":19.970562,"twenty":24.811968,"median":60.230946,"eighty":76.233066,"marketCap":43760769958.28},{"date":"2024-04-12","current":22.210127,"twenty":24.724973,"median":60.087513,"eighty":76.231368,"marketCap":48695880753.43},{"date":"2024-04-19","current":19.824434,"twenty":24.67437,"median":59.685929,"eighty":76.231368,"marketCap":43428123316.25},{"date":"2024-04-26","current":27.569399,"twenty":24.632461,"median":59.099143,"eighty":76.211774,"marketCap":50388614884.15},{"date":"2024-05-03","current":28.246975,"twenty":24.632461,"median":58.698834,"eighty":76.211774,"marketCap":51591334905.63},{"date":"2024-05-10","current":28.631608,"twenty":24.632461,"median":58.294655,"eighty":76.211774,"marketCap":52417993634},{"date":"2024-05-17","current":27.359172,"twenty":24.632461,"median":57.999053,"eighty":76.211774,"marketCap":50014931623.88},{"date":"2024-05-24","current":26.295016,"twenty":24.632461,"median":57.148443,"eighty":76.211774,"marketCap":47959780748.75},{"date":"2024-05-31","current":25.835927,"twenty":24.632461,"median":56.821632,"eighty":76.211774,"marketCap":47170402274.1},{"date":"2024-06-07","current":27.185502,"twenty":24.632461,"median":54.973638,"eighty":76.211774,"marketCap":49572858152.15},{"date":"2024-06-14","current":25.578201,"twenty":24.632461,"median":54.182646,"eighty":76.211774,"marketCap":46599203014.25},{"date":"2024-06-21","current":24.182023,"twenty":24.601724,"median":53.374181,"eighty":76.211774,"marketCap":43963372270.37},{"date":"2024-06-28","current":23.085018,"twenty":24.52097,"median":52.941971,"eighty":76.211774,"marketCap":41951586544.54},{"date":"2024-07-05","current":24.257665,"twenty":24.42909,"median":52.114695,"eighty":76.126335,"marketCap":44073022285.06},{"date":"2024-07-12","current":23.145465,"twenty":24.362093,"median":50.962964,"eighty":76.007881,"marketCap":42114070162.68},{"date":"2024-07-19","current":24.743904,"twenty":24.261509,"median":48.636011,"eighty":75.725057,"marketCap":45023334746.52},{"date":"2024-07-26","current":24.124191,"twenty":24.259675,"median":45.914186,"eighty":75.725057,"marketCap":44058800695.61},{"date":"2024-08-02","current":26.065503,"twenty":24.258238,"median":44.240897,"eighty":75.714095,"marketCap":47576541674.03},{"date":"2024-08-09","current":25.679891,"twenty":24.258238,"median":42.296244,"eighty":75.652473,"marketCap":47185094026.29},{"date":"2024-08-16","current":25.527838,"twenty":24.258238,"median":41.256127,"eighty":75.45826,"marketCap":46923935239.6},{"date":"2024-08-23","current":22.665763,"twenty":24.201795,"median":38.801967,"eighty":75.247824,"marketCap":41839109872.33},{"date":"2024-08-30","current":36.168378,"twenty":24.1897,"median":37.465268,"eighty":75.03531,"marketCap":44876256274.27},{"date":"2024-09-06","current":34.597248,"twenty":24.1897,"median":37.077818,"eighty":74.880002,"marketCap":42947533956.31},{"date":"2024-09-13","current":34.639293,"twenty":24.1897,"median":36.330754,"eighty":74.880002,"marketCap":42887168239.81},{"date":"2024-09-20","current":35.541383,"twenty":24.189037,"median":36.128819,"eighty":74.831744,"marketCap":44267938588.18},{"date":"2024-09-27","current":42.196291,"twenty":24.189037,"median":36.114961,"eighty":74.465084,"marketCap":52872923160.24},{"date":"2024-10-04","current":50.368273,"twenty":24.189037,"median":36.114961,"eighty":74.120348,"marketCap":62825931671.14},{"date":"2024-10-10","current":47.792548,"twenty":24.1897,"median":36.12189,"eighty":73.967502,"marketCap":59227145527.94},{"date":"2024-10-18","current":45.537958,"twenty":24.189037,"median":36.114961,"eighty":73.471533,"marketCap":56138881644.42},{"date":"2024-10-25","current":50.616633,"twenty":24.189037,"median":36.114961,"eighty":73.239026,"marketCap":62395879897.68},{"date":"2024-11-01","current":52.399462,"twenty":24.189037,"median":36.114961,"eighty":72.854798,"marketCap":54868136837.74},{"date":"2024-11-08","current":55.36443,"twenty":24.189037,"median":36.114961,"eighty":72.748942,"marketCap":57533539621.1},{"date":"2024-11-15","current":52.107585,"twenty":24.189037,"median":36.114961,"eighty":72.665102,"marketCap":53739845711.17},{"date":"2024-11-22","current":51.090295,"twenty":24.189037,"median":36.114961,"eighty":72.250421,"marketCap":52665730576.35},{"date":"2024-11-29","current":53.815978,"twenty":24.189037,"median":36.114961,"eighty":72.250421,"marketCap":55438257868.2},{"date":"2024-12-06","current":55.392866,"twenty":24.189037,"median":36.114961,"eighty":72.250421,"marketCap":56928274710.83},{"date":"2024-12-13","current":52.216813,"twenty":24.189037,"median":36.114961,"eighty":72.250421,"marketCap":53558270582.35},{"date":"2024-12-20","current":50.781165,"twenty":24.189037,"median":36.114961,"eighty":72.250421,"marketCap":51854942477.52},{"date":"2024-12-27","current":46.737374,"twenty":24.189037,"median":36.114961,"eighty":72.250421,"marketCap":47688619383.79},{"date":"2025-01-03","current":44.438755,"twenty":24.189037,"median":36.114961,"eighty":72.188571,"marketCap":45387610620.66},{"date":"2025-01-10","current":41.206146,"twenty":24.189037,"median":36.114961,"eighty":71.51534,"marketCap":41926513940.65},{"date":"2025-01-17","current":41.771419,"twenty":24.189037,"median":36.114961,"eighty":71.053449,"marketCap":42535968335.12},{"date":"2025-01-24","current":41.043325,"twenty":24.189037,"median":36.114961,"eighty":70.932364,"marketCap":42056430403.53},{"date":"2025-01-28","current":40.900372,"twenty":24.1897,"median":36.12189,"eighty":70.86823,"marketCap":42129583514.76},{"date":"2025-02-07","current":43.177922,"twenty":24.188373,"median":36.110703,"eighty":70.645259,"marketCap":44223945657.28},{"date":"2025-02-14","current":46.481457,"twenty":24.188373,"median":36.110703,"eighty":70.299051,"marketCap":47493818238.83},{"date":"2025-02-21","current":51.744919,"twenty":24.188373,"median":36.110703,"eighty":69.792817,"marketCap":53161889762.97},{"date":"2025-02-28","current":47.441016,"twenty":24.188373,"median":36.110703,"eighty":69.31946,"marketCap":48579496893.78},{"date":"2025-03-07","current":47.591446,"twenty":24.187103,"median":36.106445,"eighty":69.037018,"marketCap":48929203146.04},{"date":"2025-03-14","current":48.924348,"twenty":24.187103,"median":36.106445,"eighty":68.6443,"marketCap":50317871814.51},{"date":"2025-03-21","current":46.034877,"twenty":24.187103,"median":36.106445,"eighty":68.469518,"marketCap":47327508856.9},{"date":"2025-03-28","current":102.518086,"twenty":24.187103,"median":36.106445,"eighty":68.300647,"marketCap":44451368005.96},{"date":"2025-04-03","current":100.841699,"twenty":24.187103,"median":36.106445,"eighty":68.300647,"marketCap":43638132556.59},{"date":"2025-04-11","current":88.323853,"twenty":24.187103,"median":36.106445,"eighty":68.300647,"marketCap":37967264542.74},{"date":"2025-04-17","current":86.218396,"twenty":24.188373,"median":36.110703,"eighty":68.308627,"marketCap":37151116919.86},{"date":"2025-04-25","current":89.034454,"twenty":24.185833,"median":36.09533,"eighty":68.310143,"marketCap":38397675392.47}],"updateTime":1745836795995}}}